Loading
Latest filing published 07 Mar 2025 for Enfusion, Inc., €33k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Bronwen Bastone in Enfusion, Inc., where the filings describe the role as senior executive. Between 15 June 2022 and 21 April 2025, the trades on record add up to 43 filings.
On the market, this insider has only sold: 13 sales, €614k in total. Besides market trades, the filings include 27 share grants. Since January 2025: no purchases and 3 sales on the market.
Most recently, on 21 April 2025, the filings show a transaction in Enfusion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations